A mathematical model for HIV treatment with time-varying antiretroviral therapy

References

• Adams , B. M. , Banks , H. T. , Davidian , M. , Hee-Dae , K. , Tran , H. T. and Wynne , S. N. 2005 . HIV dynamics: Modeling, data analysis, and optimal treatment protocols . J. Comput. Appl. Math. , 184 : 10 – 49 .
   Web of Science ®Google Scholar
• Bofill , M. , Janossy , G. , Lee , C. A. , Macdonald-Burns , D. , Phillips , A. N. , Sabin , C. , Timms , A. , Johnson , M. A. and Kernoff , P. B. 1992 . Laboratory control values for CD4 and CD8 T lymphocytes: Implications for HIV-1 diagnosis . Clin. Exp. Immunol. , 88 : 243 – 252 .
   PubMed Web of Science ®Google Scholar
• Bonhoeffer , S. , Rembiszewski , M. , Ortiz , G. M. and Nixon , D. F. 2000 . Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection . AIDS , 1 ( 15 ) : 2313 – 2322 .
   Google Scholar
• Boyle , B. Introduction to HIV Available at http://www.healthyplace.com/sex/diseases/introduction-to-hiv/menu-id-982/
   Google Scholar
• Burg , D. , Rong , L. , Neumann , A. U. and Dahari , H. 2009 . Mathematical modeling of viralkinetics under immune control during primary HIV-1 infection . J. Theor. Biol. , doi:10.1016/j.jtbi.2009.04.010
   PubMedGoogle Scholar
• Cohen , C. J. 2005 . EuroSIDA study confirms ability of most HAART regimens to decrease rates of illness and death . The Body , February 24
   Google Scholar
• Cohen , C. J. and Boyle , B. A. 2004 . Antiretroviral therapy: The “when to start” debates . Clin. Infect. Dis. , 39 : 1705 – 1708 .
   PubMedGoogle Scholar
• De Leenheer , P. 2009 . Within-Host virus models with periodic antiviral therapy . Bull. Math. Biol. , 71 : 189 – 210 .
   PubMedGoogle Scholar
• De Leenheer , P. and Smith , H. L. 2003 . Virus dynamics: A global analysis . SIAM J. Appl. Math. , 63 : 1313 – 1327 .
   Web of Science ®Google Scholar
• Fauci , A. S. 1993 . Immunopathogenesis of HIV infection . J. Acquir. Immune Defic. Syndr , 6 ( 6 ) : 655 – 662 .
   PubMedGoogle Scholar
• HIV and AIDS. Available at http://www.nhs.uk/Conditions/HIV/Pages/Introduction.aspx?url=Pages/What-is-it.aspx&r=1&rtitle=HIV+-+Introduction
   Google Scholar
• Huang , Y. 2008 . Long-term HIV dynamic models incorporating drug adherence and resistance to treatment for prediction of viriological responses . Comput. Statist. Data Anal. , 52 : 3765 – 3778 .
   Web of Science ®Google Scholar
• Hyman , J. M. and Li , J. 2005 . The reproductive number for an HIV model with differential infectivity and staged progression . Linear Algebra Appl. , 398 : 101 – 116 .
   Web of Science ®Google Scholar
• Kaufmann , G. R. , Cunningham , P. , Kelleher , A. D. , Zaunders , J. , Carr , A. , Vizzard , J. , Law , M. and Cooper , D. A. 1998 . Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection . The Sydney Primary HIV Infection Study Group. J. Infect. Dis , 178 ( 6 ) : 1812 – 1815 .
   PubMedGoogle Scholar
• Kepler , T. B. and Perelson , A. S. 1998 . Drug concentration heterogeneity facilitates the evolution of drug resistance . Proc. Natl. Acad. Sci. USA , 95 : 11514 – 11519 .
   PubMed Web of Science ®Google Scholar
• Kirschner , D. E. and Webb , G. F. 1997 . Understanding drug resistance for monotheraphy treatment of HIV infection . Bull. Math. Biol. , 59 : 763 – 786 .
   PubMed Web of Science ®Google Scholar
• Koup , R. A. , Safrit , J. T. , Cao , Y. , Andrews , C. A. , Mcleod , G. , Borkowsky , W. , Farthing , C. and Ho , D. D. 1994 . Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome . J. Virol , 68 ( 7 ) : 4650 – 4655 .
   PubMed Web of Science ®Google Scholar
• Lindback , S. , Karlsson , A. C. , Mittler , J. , Blaxhult , A. , Carlsson , M. , Briheim , G. , Sonnerborg , A. and Gaines , H. 2000 . Viral dynamics in primary HIV-1 infection . Karolinska Institute Primary HIV Infection Study Group. AIDS , 14 ( 15 ) : 2283 – 2291 .
   Google Scholar
• Mclean , A. R. and Nowak , M. A. 1992 . Competition between zidovudine-sensitive and zidovudine-resistant strains of HIV . AIDS , 6 : 71 – 79 .
   PubMed Web of Science ®Google Scholar
• Mcmichael , A. How HIV fools the immune system Available at http://www.tulane.edu/dmsander/WWW/335/McMichael/McMichael.html
   Google Scholar
• Mohri , H. , Bonhoeffer , S. , Monard , S. , Perelson , A. S. and Ho , D. D. 1998 . Rapid turnover of T lymphocytes in SIV-infected Rhesus Macaques . Science , 279 : 1223 – 1227 .
   PubMedGoogle Scholar
• Murray , J. M. and Perelson , A. S. 2005 . Human immunodeficiency virus: Quasi-species and drug resistance . Multiscale Model. Simul. , 3 : 300 – 311 .
   Google Scholar
• Nowak , M. A. , Lloyd , A. L. , Vasquez , G. M. , Wiltrout , T. A. , Wahl , L. M. , Bischofberger , N. , Williams , J. , Kinter , A. , Fauci , A. S. , Hirsch , V. M. and Lifson , J. D. 1997 . Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection . J. Virol , 71 ( 10 ) : 7518 – 7525 .
   PubMed Web of Science ®Google Scholar
• Perelson , A. S. and Nelson , P. W. 1999 . Mathematical analysis of HIV-1 dynamics in vivo . SIAM Rev. , 41 : 3 – 44 .
   Web of Science ®Google Scholar
• Perelson , A. S. , Kirschner , D. E. and De Boer , R. 1993 . Dynamics of HIV infection of CD4+ T cells . Math. Biosci. , 114 : 81 – 125 .
   PubMed Web of Science ®Google Scholar
• Perelson , A. S. , Essunger , P. and Ho , D. D. 1997 . Dynamics of HIV-1 and CD4+ lymphocytes in vivo . AIDS , 11 ( Suppl. A ) : S17 – S24 .
   PubMedGoogle Scholar
• Rapin , N. , Kesmir , C. , Frankild , S. , Nielsen , M. , Lundegaard , C. , Brunak , S. and Lund , O. 2006 . Modelling the human immune system by combining bioinformatics and systems biology approaches . J. Biol. Phys. , 32 : 335 – 353 .
   PubMed Web of Science ®Google Scholar
• Ribeiro , R. M. , Bonhoeffer , S. and Nowak , M. A. 1998 . The frequency of resistant mutant virus before antiviral therapy . AIDS , 12 : 461 – 465 .
   PubMed Web of Science ®Google Scholar
• Rong , L. , Feng , Z. and Perelson , A. S. 2007 . Emergence of HIV-1 drug resistance during antiretroviral treatment . B Math. Biol. , 69 : 2027 – 2060 .
   PubMed Web of Science ®Google Scholar
• Rong , L. , Gilchrist , M. A. , Feng , Z. and Perelson , A. S. 2007 . Modeling within-host HIV-1 dynamics and the evolution of drug resistance: Trade-offs between viral enzyme function and drug susceptibility . J. Theor. Biol. , 247 : 804 – 818 .
   PubMed Web of Science ®Google Scholar
• Schmitz , J. E. , Kuroda , M. J. , Santra , S. , Sasseville , V. G. , Simon , M. A. , Lifton , M. A. , Racz , P. , Tenner-Racz , K. , Dalesandro , M. , Scallon , B. J. , Ghrayeb , J. , Forman , M. A. , Montefiori , D. C. , Rieber , E. P. , Letvin , N. L. and Reimann , K. A. 1999 . Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes . Science , 283 ( 5403 ) : 857 – 860 .
   PubMed Web of Science ®Google Scholar
• Shiri , T. , Garira , W. and Musekwa , S. D. 2005 . A two-strain HIV mathematical model to assess the effects of chemotherapy on disease parameters . Math. Biosci. Eng. , 2 : 811 – 832 .
   PubMed Web of Science ®Google Scholar
• Smith , R. J. and Wahl , L. M. 2005 . Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects . Bull. Math. Biol. , 67 : 783 – 813 .
   PubMedGoogle Scholar
• Stafford , M. A. , Corey , L. , Cao , Y. , Daar , E. S. , Ho , D. D. and Perelson , A. S. 2000 . Modeling plasma virus concentration during primary HIV infection . J. Theor. Biol. , 203 : 285 – 301 .
   PubMed Web of Science ®Google Scholar
• Tarfulea , N. E. , Blink , A. , Nelson , E. and Turpin , D. 2011 . A CTL-Inclusive mathematical model for antiretroviral treatment of HIV infection . Int. J. Biomathl. 2010 , 4 ( 1 ) : 1 – 22 .
   Google Scholar
• Wahl , L. M. and Nowak , M. A. 2000 . Adherence and drug resistance: predictions for therapy outcome . Proc. Biol. Sci , 267 ( 1445 ) : 835 – 843 .
   PubMedGoogle Scholar
• Wei , X. , Ghosh , S. K. , Taylor , M. E. , Johnson , V. A. , Emini , E. A. , Deutsch , P. , Lifson , J. D. , Bonhoeffer , S. , Nowak , M. A. , Hahn , B. H. , Saag , M. S. and Shaw , G. M. 1995 . Viral dynamics in human immunodeficiency-virus type-1 infection . Nature , 373 : 117 – 122 .
   PubMed Web of Science ®Google Scholar
• Wilson , J. D. , Ogg , G. S. , Allen , R. L. , Davis , C. , Shaunak , S. , Downie , J. , Dyer , W. , Workman , C. , Sullivan , S. , Mcmichael , A. J. and Rowland-Jones , S. L. 2000 . Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection . AIDS , 14 ( 3 ) : 225 – 233 .
   PubMedGoogle Scholar